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Cbl-bDiscoidin domain receptor 2 (DDR2), a collagen receptor tyrosine kinase, initiates signal transduc-
tion upon collagen binding, but little is known as to how DDR2 signaling is negatively regulated.
Herein we demonstrate that Cbl family member Cbl-b predominantly promotes the ubiquitination
of DDR2 upon collagen II stimulation. Cbl-b-mediated ubiquitination accelerates the degradation of
activated DDR2. Finally, the production of MMP-13, a downstream target of DDR2, is enhanced in
Cbl-b-knocked down MC3T3-E1 cells and Cbl-b-deﬁcient mouse primary synovial ﬁbroblasts. Thus,
Cbl-b, by promoting the ubiquitination and degradation of DDR2, functions as a negative regulator
in the DDR2 signaling pathway.
Structured summary of protein interactions:
DDR2 physically interacts with Cbl-b by anti tag coimmunoprecipitation (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Collagen proteins, major components of extracellular matrix
(ECM), play important roles in the regulation of cell function and
behavior aside from the maintenance of tissue structure and integ-
rity. The signals from extracellular collagens to the cells are trans-
duced by speciﬁc cell-surface receptors, including integrins and
discoidin domain receptors (DDRs) [1,2].
DDRs, consisting of DDR1 and DDR2, belong to the receptor
tyrosine kinase (RTK) subfamily and exhibit a slow but sustained
phosphorylation kinetics in response to collagen binding [3].
DDR2 expression is mainly detected in mesenchymal-derived cells
[4,5]. Growing biological evidences have demonstrated that DDR2
can regulate cell proliferation, migration, differentiation, as well as
extracellular matrix remodeling and epithelial-mesenchymal tran-
sition (EMT) [3,6–12]. Upregulation of DDR2 signaling was re-
ported to be associated with diverse human diseases, such as
arthritis and cancer [13]. Elevated expression of matrix metallo-
proteinases (MMPs) that primarily mediate the degradation of
ECM represents an important cell response to DDR2 activation[8,14,15]. However, up to date little is known as to how the
DDR2 signaling is negatively regulated or attenuated.
Covalent modiﬁcation of activated RTKs with ubiquitin, which
is carried out by a cascade of enzymatic reactions involving E1
(ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme)
and E3 (ubiquitin ligase), has been well established as a major
mechanism for negative regulation of RTK signaling [16]. Cbl fam-
ily, which consists of three homologues known as Cbl (or c-Cbl),
Cbl-b and Cbl-c (or Cbl-3) in mammals, belongs to RING-type E3
ubiquitin ligases [17]. Cbl proteins-mediated ubiquitination can
target activated tyrosine kinases for degradation, either by facili-
tating their endocytic sorting into lysosomes or by promoting their
proteasomal degradation [18]. In contrast to the wide expression
pattern of Cbl and Cbl-b, Cbl-c expression was reported to be lim-
ited in epithelial cells [19], in which DDR2 is always not expressed
[4,5]. Thus, in this study, we aimed to investigate whether DDR2
can be negatively regulated by Cbl or Cbl-b.
2. Material and methods
2.1. Materials
The detailed information for the regents and antibodies were
described in Supplementary data. The sense sequence of Cbl-b
small interfering RNA (siRNA) is: 50-GCUUCUCUUGUUAGUUUAA
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Ala mutation, Cbl-b-W400A) as well as HA-tagged ubiquitin plas-
mids were used as described previously [20]. Wild type DDR2 or
its mutants were tagged with Myc and expressed using
pcDNA3.1(-) vectors [21].
2.2. Cell culture and treatment protocols
Cell culture and transfection of HEK 293T and MC3T3-E1 cells
were described in Supplementary data. Primary mouse synovial
ﬁbroblasts were established by cultivating type B synoviocytes
from the synovial tissues of Cbl-b+/+ or Cbl-b/ mice on the B6
background as previously described [21]. The animal protocol
was approved by the Committee on the Ethics of Animal Experi-
ments of The La Jolla Institute for Allergy and Immunology (USA).
Synovial ﬁbroblasts were used between the fourth to eighth pas-
sages. For collagen stimulation, collagen II was dissolved in 0.2%
acetic acid at the concentration of 2 mg/mL and coated onto cul-
ture plates (6 lg/cm2). To analyze MMP-13 production in synovial
ﬁbroblasts, the cells were treated with collagen II in serum-free
media for 48 h. Cell lysates and the culture medium were both col-
lected and the culture medium was concentrated 20-fold before
detection.
2.3. In vivo ubiquitination assay, co-immunoprecipitation
and immunoblot
For the detection of ubiquitinated DDR2, cells were lysed in
Nonidet P-40 (NP-40) lysis buffer [1% NP-40, 20 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 5 mM EDTA, 5 mM sodium pyrophosphate,
2 mM orthovanadate and 10 lg/ml of both aprotinin and leupep-
tin]. The cell lysates were heated at 95 C for 20 min in the pres-
ence of 1% SDS to disrupt non-speciﬁc protein interactions. The
heated cell lysates were then diluted to make the ﬁnal concentra-
tion of SDS to 0.1% for further immunoprecipitation (IP) with
antibodies against Myc or DDR2. Anti-Myc or anti-DDR2 immuno-
precipitates were separated by SDS–PAGE and immunoblot was
performed using antibodies recognizing HA or Ub. To detect the
association of DDR2 with Cbl-b, the transfected cells were lysed
in Nonidet P-40 (NP-40) buffer and then directly subjected to co-
immunoprecipitation.
2.4. Pulse-chase assays
HEK 293T cells were transfected with Myc-DDR2 together with
pEF or Cbl-b. 16 h after transfection, the cells were cultured on col-
lagen II-coated plates for another 2 h and then treated with methi-
onine-free DMEM containing 5% dialysed FCS for 1 h, followed by
labeling with 100 lCi [35S] methionine (ICN Biomedicals, Inc.,
Costa Mesa, CA) for 1 h. Cells were then washed three times and
cultured for various durations in complete DMEMmedium. At each
time point, the cell lysates were prepared and then immunoprecip-
itated with anti-Myc. After separation of the immunoprecipitates,
the gel was dried and autoradiographied at 70 C overnight. The
radio-labeled protein bands were quantiﬁed using NIH Image J
software.
2.5. Real time PCR
Cbl-b primer sequences were 50-ACGGGTTCACCAAAGTCTTC-30
(forward) and 50-ATTGGTGGAGGTCTTTCAGG (reverse). MMP-13
and GAPDH primer sequences were the same as described previ-
ously [9,21]. The procedures of RNA isolation and real time PCR
were described in Supplementary data.2.6. Statistical analysis
All experiments were performed independently in triplicate.
The results are expressed as the mean ± S.D. of triplicate indepen-
dent samples. A student’s t test was used to examine the differ-
ences between the two groups of data. Differences with P < 0.05
were considered statistically signiﬁcant.
3. Results
3.1. Cbl-b predominantly promotes DDR2 ubiquitination
To investigate whether Cbl or Cbl-b is involved in the ubiquiti-
nation of DDR2, HEK 293T cells were transiently co-transfected
with Myc-DDR2, HA-Ub and Xpress-Cbl or Xpress-Cbl-b, and then
plated onto native collagen II-coated surface to stimulate DDR2
phosphorylation. It was shown that collagen II stimulation led to
the formation of a high molecular weight smear that is indicative
of ubiquitinated DDR2 protein. The intensity of this smear was en-
hanced sharply by the ectopic expression of Cbl-b, but only slightly
by Cbl (Fig. 1A, upper panel). Cbl-b-caused increase in the ubiquiti-
nation level of DDR2 was consistent with the decrease in the
amount of phosphorylated but non-ubiquitinated form of DDR2
(Fig. 1A, middle panel). To further conﬁrm that the ubiquitination
of DDR2 directly correlates with its phosphorylation status, we
measured the ubiquitination ability of the indicated point mutants
of DDR2 (Fig. 1B). As previously reported [22], Y736F and Y741F
DDR2 represent phosphorylation-null mutants, while Y740F mu-
tant exhibits enhanced phosphorylation. We found that Y740F
DDR2 had a higher ubiquitination level than wild-type DDR2. In
contrast, Y736F and Y741F mutants were resistant to induction
of ubiquitination (Fig. 1B). These data collectively suggest that
Cbl-b may serve as a major regulator of collagen-induced DDR2
ubiquitination.
We then examined whether DDR2 interacts with Cbl-b. HEK
293T cells were co-transfected with Myc-DDR2 and Xpress-Cbl-b
in the presence or absence of type II collagen and the cell lysates
were then subjected to co-immunoprecipitation assay. As shown
in Fig. 1C, Cbl-b could be detected in anti-Myc immunoprecipitates
from collagen II-treated cells but not in those from un-stimulated
cells. Thus, upon activation, DDR2 can form complex with Cbl-b.
Considering that the E3 ligase activity of Cbl-b can be abolished
by a Trp to Ala mutation (W400A) in its RING ﬁnger domain [20],
we examined the capability of the RING-defective Cbl-b WA to reg-
ulate DDR2 ubiquitination. As shown in Fig. 1D, Cbl-b WA mutant
failed to mediate the conjugation of ubiquitin to DDR2, suggesting
that the functional RING ﬁnger domain in Cbl-b is indispensible for
its modulation of DDR2 ubiquitination.
3.2. Cbl-b overexpression decreases the protein stability of DDR2
Because ubiquitin-modiﬁed tyrosine kinases can be degraded in
either lysosome or proteasome [18], we then examined which
pathway is linked to DDR2 ubiquitination. HEK293T cells co-
expressing Myc-DDR2, HA-Ub and Xpress-Cbl-b were stimulated
with collagen II for 2 h, and then treated with proteasome or lyso-
some inhibitor for 30 min. MG132, a potent proteasome inhibitor,
resulted in a dramatic accumulation of ubiquitinated DDR2. In con-
trast, lysosomal inhibition with NH4Cl showed no obvious effects
(Fig. 2A). This indicates that proteasome pathway might partici-
pate in further processing of ubiquitinated DDR2 protein.
We then examined whether the protein stability of DDR2 was
affected by Cbl-b using pulse-chase experiment. As shown in
Fig. 2B, in both control and Cbl-b-expressing cells, the newly
synthesized DDR2 protein (lower bands) were converted into
Fig. 1. Cbl-b predominantly promotes the ubiquitination of DDR2. (A and B) Cbl-b promotes the ubiquitination of DDR2 in a DDR2-activation-dependent manner. HEK 293T
cells were transfected as indicated and treated with or without collagen II for 2 h. Ubiquitinated DDR2 was analyzed by immunoprecipitation (IP) with anti-Myc and
immunoblot with anti-haemagglutinin (HA). The same membrane was reprobed with anti-Myc and anti-phosphotyrosine (pTyr). (Ub)n-DDR2: ubiquitinated DDR2; pDDR2:
phosphorylated DDR2. (C) DDR2 interacts with Cbl-b in a collagen-dependent manner. HEK 293T cells were transfected as indicated and treated with or without collagen II
for 2 h. Cell lysates were subject to IP with anti-Myc antibody followed by immunoblot with anti-Xpress, anti-phosphotyrosine (pTyr) and anti-Myc antibodies, respectively.
The whole cell lysates were detected by immunoblot with anti-Xpress antibody. (D) Cbl-b-promoted DDR2 ubiquitination relies on intact RING ﬁnger domain. Cells that
express Myc-DDR2, HA-Ub, wild-type Cbl-b or RING-ﬁnger mutant Cbl-b (Cbl-b WA) were treated and analyzed as in A.
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bands (upper bands) (Fig. 2B). There was no signiﬁcant difference
in the band intensities of either unphosphorylated or phosphory-
lated DDR2 at 2-hour time point between the control and
Cbl-b-overexpressing cells. However, after 4 h of chasing, Cbl-b
overexpression dramatically reduced the levels of phosphorylated
DDR2, but not that of unphosphorylated DDR2, suggesting that
Cbl-b causes speeding up the degradation of phosphorylated
DDR2 (Fig. 2B and C).
3.3. Cbl-b knockdown enhances the protein stability of DDR2 as well as
the expression level of its downstream target in pre-osteoblasts
In our previous study, DDR2 was demonstrated to play crucial
roles in the differentiation of pre-osteoblastic MC3T3-E1 cells [9].
Therefore, this cell line was utilized to measure the effects of
Cbl-b knockdown on the ubiquitination and degradation of endog-
enous DDR2 as well as on the expression level of its downstream
target. The result of real time PCR showed that the mRNA expres-
sion of Cbl-b, albeit not affected by collagen II treatment, had anapproximate 60% reduction by the introduction of Cbl-b siRNA
(Fig. 3A). Consistent with the results from HEK293T cells, there
was a dramatic accumulation of ubiquitinated DDR2 proteins in
control MC3T3-E1 cells upon collagen stimulation. However, such
an effect was almost abrogated by siRNA-mediated Cbl-b silencing
(Fig. 3B). To detect the alterations in DDR2 protein stability, the
control siRNA- or Cbl-b siRNA-transfected cells were treated with
protein synthesis inhibitor CHX for various durations in the pres-
ence or absence of collagen II. Immunoblot analysis showed that
after a 3 h treatment with CHX, collagen II stimulation did not alter
the protein levels of DDR2 in both cells. In sharp contrast, 6 h after
the addition of CHX, collagen II resulted in signiﬁcant reduction of
DDR2 protein in control cells, which was attenuated by Cbl-b
knockdown (Fig. 3C). The collagen II-induced decrease of DDR2
protein could be almost abrogated by the addition of MG132
(Fig. 3D). These results suggested that Cbl-b might enhance the
ubiquitination of endogenous activated DDR2 protein and then
facilitate its degradation in proteasome.
Our previous molecular evidences indicated that DDR2 signal-
ing can directly up-regulate the transcription of MMP-13 [21], a
Fig. 2. Cbl-b overexpression reduces the stability of activated DDR2. (A) HEK 293T cells co-expressing Myc-DDR2, Xpress-Cbl-b and HA-Ub were treated with collagen II for
2 h. Thirty minutes before cell collection, 50 lMMG132 or 20 mM NH4Cl were applied. The cell lysates were subjected to IP with anti-Myc antibody followed by immunoblot
with anti-HA and anti-Myc antibodies. (B and C) HEK 293T cells were transfected as indicated, stimulated with collagen II and pulse-labeled as in Section 2. Myc-DDR2 levels
were analyzed with IP using anti-Myc antibody followed by autoradiograph (B). Results were quantiﬁed using densitometry scanning and expressed as relative ratio by
setting the density of phosphorylated DDR2 (pDDR2) at 2 h and that of DDR2 at 0 h as 1. The experiment was repeated in triplicate and the representative result was shown.
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MMP-13 was chosen as a molecular marker to evaluate the
consequence of Cbl-b knockdown on DDR2 downstream events.
In control MC3T3-E1 cells, the mRNA levels of MMP-13 were sig-
niﬁcantly increased by collagen II treatment, reinforcing collagen
II–DDR2–MMP13 axis. Such MMP13 induction by collagen II was
further enhanced by Cbl-b silence (Fig. 3E). Together, our ﬁndings
suggest that Cbl-b-mediated DDR2 modiﬁcation is physiologically
relevant in pre-osteoblastic cells.
3.4. Cbl-b deﬁciency is associated with elevated DDR2-MMP-13
signaling pathway in mouse primary synovial ﬁbroblasts
Our published data have shown that collagen II–DDR2–MMP-13
axis in synovial ﬁbroblasts may be associatedwith the articular car-
tilage destruction in rheumatoid arthritis [21]. To further conﬁrm
the physiological link between DDR2 and Cbl-b, we compared the
mRNA and protein levels of MMP-13 in primary synovial ﬁbroblasts
isolated from wild type or Cbl-b knockout mice. As expected, real
time PCR showed that there was no signiﬁcant difference in
MMP-13 mRNA expression between wild type and Cbl-b-deﬁcient
synovial ﬁbroblasts under resting conditions. However, upon colla-
gen II treatment, Cbl-b/ synovial ﬁbroblasts expressed higher le-
vel of MMP-13 than their wild-type counterparts (Fig. 4A). MMP-13
protein levels, either in the cell lysates or in the culture media
(supernatant), were similarly increased by Cbl-b deﬁciency upon
collagen II treatment, as measured by immunoblot (Fig. 4B). Taken
together, it is suggested that Cbl-b may function as a negativeregulator of collagen II–DDR2–MMP-13 signaling pathway in
synoviocytes.
4. Discussion
In this study, we have shown for the ﬁrst time that Cbl-b is
associated with DDR2 and promotes its ubiquitination, resulting
in its degradation. We further explored the physiological relevance
of DDR2 regulation by Cbl-b and demonstrated that Cbl-b-medi-
ated DDR2 ubiquitination and degradation can negatively regulate
collagen–DDR2–MMP-13 signaling axis in pre-osteoblastic cells
and primary synovial ﬁbroblasts. Hence, Cbl-b represents the ﬁrst
negative regulator identiﬁed in DDR2 signaling pathway.
Because of structural homology, Cbl and Cbl-b always have
overlapping or similar functions [24–28]. However, they also dis-
play different expression pattern and in vivo function [18]. As for
the role of Cbl and Cbl-b in some PTK signaling, it can be different
or even opposite [26,29]. Although our current data supported the
notion that collagen-induced ubiquitination of DDR2 was predom-
inantly facilitated by Cbl-b, we cannot exclude the possibility that
Cbl may also play some important roles in DDR2 signaling, given
that we identiﬁed an interaction between Cbl and DDR2 as well
(data not shown). In addition, aside from possessing ubiquitin li-
gase activity, Cbl has been well documented as an adaptor protein
[18,26]. As such, whether and how Cbl is involved in DDR2 signal-
ing still awaits further investigation.
Another notable ﬁnding in this study is that Cbl-b-mediated
ubiquitination accelerates the degradation of phosphorylated
Fig. 3. Cbl-b knockdown increases the stability of activated DDR2 as well as collagen-induced expression of MMP-13 in MC3T3-E1 cells. (A) MC3T3-E1 cells were transfected
with scramble siRNAs or siRNA against Cbl-b (si-Cbl-b), and 48 h later, the transfected cells were stimulated with or without collagen II for 24 h. The relative mRNA
expression of Cbl-b was analyzed by real time PCR. (B) Ubiquitinated DDR2 was analyzed by IP with anti-DDR2 antibody followed by immunoblot with anti-Ub antibody. (C)
Fourty-eight hours after transfection with Cbl-b siRNA, MC3T3-E1 cells were seeded on plastic or collagen II-coated plates for 2 h, and then treated with CHX for the indicated
duration. The protein level of DDR2 was analyzed by immunoblot. (D) Two hours after culturing on plastic or collagen II-coated surface, MC3T3-E1 cells were treated with
CHX for 6 h and 2 h before cell collection, 50 lM MG132 was added. The cell lysates were immunoblotted with antibody against DDR2. (E) The cells in A were subjected to
real time PCR analysis of MMP-13 mRNA expression. ⁄ P < 0.05; ⁄⁄⁄ P < 0.001.
Fig. 4. Collagen II-induced MMP-13 production is enhanced in Cbl-b/synovial ﬁbroblasts. Cbl-b+/+and Cbl-b/synovial ﬁbroblasts were seeded onto plastic or collagen II-
coated surface for 24 h. (A) MMP-13 mRNA levels were analyzed by real-time PCR. (B) MMP-13 protein in both cell lysates and culture mediumwere analyzed by immunoblot
with anti-MMP-13 antibody as described in Section 2. ⁄⁄ P < 0.01.
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tion either in proteasome through K48-linked poly-ubiquitination
or in lysosome through mono-, multiple mono- and K63-linked
poly-ubiquitination [18,30–33]. In this study, although we could
not distinguish whether DDR2 is multimono- or poly-ubiquitinat-
ed by Cbl-b, we showed that ubiquitinated DDR2 can be stabilized
by proteasome inhibitor MG-132, rather than a lysosome inhibitor,
NH4Cl. This suggests that the proteasome pathway is involved in
processing ubiquitinated DDR2. However, because proteasome
inhibitors might affect lysosome function by interfering with ubiq-
uitin recycling or lysosome proteins turnover [34], we cannot com-
pletely rule out the possibility of endocytic trafﬁcking and
lysosome degradation of DDR2.Our present study showed that Cbl-b promotes DDR2 ubiquiti-
nation and attenuates collagen II-induced MMP-13 expression in
pre-osteoblasts and synovial ﬁbroblasts, respectively. Previously,
we and others demonstrated that collagen II–DDR2–MMP-13 axis
may contribute to articular cartilage destruction in arthritis
[14,21]. These observations collectively suggest that Cbl-b abun-
dance may impact DDR2-related pathogenesis. Indeed, we docu-
mented that Cbl-b/ mice exhibit synovial hyperplasia and
erosion of cartilage in a collagen-induced autoimmune arthritis
model [35]. Although such phenotype could be partially explained
by aberrant immune response [35] and increased osteoclasts activ-
ity [36] caused by Cbl-b deﬁciency, our current study can provide
additional mechanism from the aspect of synovial ﬁbroblasts.
1514 J. Yu et al. / FEBS Letters 588 (2014) 1509–1514Thus, the appropriate Cbl-b level contributes to appropriate DDR2
signaling and the functional consequence.
In conclusion, the ﬁndings from this study not only shed light
on the regulation of DDR2 signaling and function, but also widen
our insight by revealing an un-described role of Cbl-b toward a un-
ique collagen RTK, DDR2.
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